Cargando…
Clinical Outcomes Of Using Nebulized Budesonide As The Initial Treatment For Acute Exacerbations Of Chronic Obstructive Pulmonary Disease: A Post-Hoc Analysis
PURPOSE: The current guidelines recommend the use of systemic corticosteroids (SCS) as the optimal treatment for acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The aim of this real-world study was to evaluate whether nebulized budesonide (NBS) could also be used as an initial...
Autores principales: | Zheng, Jin-Ping, Zhang, Jing, Ma, Li-Jun, Chen, Ping, Huang, Mao, Ou, Xue-Mei, Zhao, Zi-Wen, Jiang, Shu-Juan, Cao, Jie, Yao, Wanzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889964/ https://www.ncbi.nlm.nih.gov/pubmed/31819404 http://dx.doi.org/10.2147/COPD.S196615 |
Ejemplares similares
-
Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhang, Rui, et al.
Publicado: (2020) -
Comparison of the Efficacy of Budesonide Nebulizer Suspension and Budesonide Inhalation Suspension in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Emami Ardestani, Mohammad, et al.
Publicado: (2018) -
Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China
por: Zhang, Jing, et al.
Publicado: (2019) -
A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease
por: Gu, Yong-Li, et al.
Publicado: (2022) -
Comparison of the Clinical Outcomes Between Nebulized and Systemic Corticosteroids in the Treatment of Acute Exacerbation of COPD in China (CONTAIN Study): A Post Hoc Analysis
por: Chen, Yahong, et al.
Publicado: (2020)